These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 18976962

  • 1. A single-blind, placebo run-in study of duloxetine for activity-limiting osteoarthritis pain.
    Sullivan MD, Bentley S, Fan MY, Gardner G.
    J Pain; 2009 Feb; 10(2):208-13. PubMed ID: 18976962
    [Abstract] [Full Text] [Related]

  • 2. A single-blind placebo run-in study of venlafaxine XR for activity-limiting osteoarthritis pain.
    Sullivan M, Bentley S, Fan MY, Gardner G.
    Pain Med; 2009 Feb; 10(5):806-12. PubMed ID: 19496959
    [Abstract] [Full Text] [Related]

  • 3. A randomized placebo-controlled trial of duloxetine in patients with major depressive disorder and associated painful physical symptoms.
    Gaynor PJ, Gopal M, Zheng W, Martinez JM, Robinson MJ, Marangell LB.
    Curr Med Res Opin; 2011 Oct; 27(10):1849-58. PubMed ID: 21838411
    [Abstract] [Full Text] [Related]

  • 4. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.
    Kivitz A, Ma C, Ahdieh H, Galer BS.
    Clin Ther; 2006 Mar; 28(3):352-64. PubMed ID: 16750450
    [Abstract] [Full Text] [Related]

  • 5. Duloxetine versus placebo in the treatment of major depressive disorder and associated painful physical symptoms: a replication study.
    Gaynor PJ, Gopal M, Zheng W, Martinez JM, Robinson MJ, Hann D, Marangell LB.
    Curr Med Res Opin; 2011 Oct; 27(10):1859-67. PubMed ID: 21838410
    [Abstract] [Full Text] [Related]

  • 6. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
    Arnold LM, Lu Y, Crofford LJ, Wohlreich M, Detke MJ, Iyengar S, Goldstein DJ.
    Arthritis Rheum; 2004 Sep; 50(9):2974-84. PubMed ID: 15457467
    [Abstract] [Full Text] [Related]

  • 7. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
    Hellerstein DJ, Stewart JW, McGrath PJ, Deliyannides DA, Batchelder ST, Black SR, Withers A, O'Shea D, Chen Y.
    J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348
    [Abstract] [Full Text] [Related]

  • 8. Responsiveness of the Intermittent and Constant Osteoarthritis Pain (ICOAP) scale in a trial of duloxetine for treatment of osteoarthritis knee pain.
    Risser RC, Hochberg MC, Gaynor PJ, D'Souza DN, Frakes EP.
    Osteoarthritis Cartilage; 2013 May; 21(5):691-4. PubMed ID: 23485934
    [Abstract] [Full Text] [Related]

  • 9. Maintenance of effect of duloxetine in patients with chronic low back pain: a 41-week uncontrolled, dose-blinded study.
    Skljarevski V, Zhang S, Chappell AS, Walker DJ, Murray I, Backonja M.
    Pain Med; 2010 May; 11(5):648-57. PubMed ID: 20546509
    [Abstract] [Full Text] [Related]

  • 10. Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. Hyalgan Study Group.
    Altman RD, Moskowitz R.
    J Rheumatol; 1998 Nov; 25(11):2203-12. PubMed ID: 9818665
    [Abstract] [Full Text] [Related]

  • 11. Long-term safety, tolerability, and efficacy of duloxetine in the treatment of fibromyalgia.
    Mease PJ, Russell IJ, Kajdasz DK, Wiltse CG, Detke MJ, Wohlreich MM, Walker DJ, Chappell AS.
    Semin Arthritis Rheum; 2010 Jun; 39(6):454-64. PubMed ID: 19152958
    [Abstract] [Full Text] [Related]

  • 12. Pain response profile of patients with fibromyalgia treated with duloxetine.
    Bradley LA, Wohlreich MM, Wang F, Gaynor PJ, Robinson MJ, D'Souza DN, Mease PJ.
    Clin J Pain; 2010 Jun; 26(6):498-504. PubMed ID: 20551724
    [Abstract] [Full Text] [Related]

  • 13. Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation.
    Wohlreich MM, Mallinckrodt CH, Prakash A, Watkin JG, Carter WP.
    Depress Anxiety; 2007 Jun; 24(1):41-52. PubMed ID: 16845641
    [Abstract] [Full Text] [Related]

  • 14. Women with pain due to osteoarthritis: the efficacy and safety of a once-daily formulation of tramadol.
    Kean WF, Bouchard S, Roderich Gossen E.
    Pain Med; 2009 Sep; 10(6):1001-11. PubMed ID: 19671089
    [Abstract] [Full Text] [Related]

  • 15. Morphine sulfate and naltrexone hydrochloride extended release capsules in patients with chronic osteoarthritis pain.
    Katz N, Hale M, Morris D, Stauffer J.
    Postgrad Med; 2010 Jul; 122(4):112-28. PubMed ID: 20675975
    [Abstract] [Full Text] [Related]

  • 16. Time course of improvement of different symptom clusters in patients with major depression and pain treated with duloxetine or placebo.
    Demyttenaere K, Desaiah D, Petit C, Croenlein J, Brecht S.
    Curr Med Res Opin; 2012 Jan; 28(1):41-8. PubMed ID: 22126422
    [Abstract] [Full Text] [Related]

  • 17. Duloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee pain: a 13-week, randomized, placebo-controlled trial.
    Chappell AS, Ossanna MJ, Liu-Seifert H, Iyengar S, Skljarevski V, Li LC, Bennett RM, Collins H.
    Pain; 2009 Dec; 146(3):253-260. PubMed ID: 19625125
    [Abstract] [Full Text] [Related]

  • 18. Time course of depression-symptom improvement during treatment with duloxetine.
    Hirschfeld RM, Mallinckrodt C, Lee TC, Detke MJ.
    Depress Anxiety; 2005 Dec; 21(4):170-7. PubMed ID: 16035056
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of duloxetine 30 mg/d in patients with fibromyalgia: a randomized, double-blind, placebo-controlled study.
    Arnold LM, Zhang S, Pangallo BA.
    Clin J Pain; 2012 Dec; 28(9):775-81. PubMed ID: 22971669
    [Abstract] [Full Text] [Related]

  • 20. Oxymorphone extended-release tablets relieve moderate to severe pain and improve physical function in osteoarthritis: results of a randomized, double-blind, placebo- and active-controlled phase III trial.
    Matsumoto AK, Babul N, Ahdieh H.
    Pain Med; 2005 Dec; 6(5):357-66. PubMed ID: 16266356
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.